newsfilter
← Latest News
Business Wire·

Cortexyme Announces Pipeline Update and Anticipated 2022 Milestones

Next generation lysine gingipain inhibitor COR588 with novel structure and improved pharmacologic and safety profile prioritized for Alzheimer's development Additional pipeline includes therapeutics in development for coronavirus infection, periodont